Hospitalization Rates in Patients with Heart Failure and Reduced Ejection Fraction Initiating Sacubitril/Valsartan or Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers: A Retrospective Cohort Study

被引：0
|
作者：
Emma Houchen
Emil Loefroth
Raymond Schlienger
Clare Proudfoot
Stefano Corda
Sibasish Saha
Sarvesh K. Satwase
Rachel Studer
机构：
[1] Novartis Ireland Ltd.,
[2] Novartis Sweden AB,undefined
[3] Novartis Pharma AG,undefined
[4] Novartis Healthcare Pvt. Ltd,undefined
[5] Medical and Knowledge Solutions,undefined
[6] Novartis Global Service Center,undefined
来源：
Cardiology and Therapy | 2022年 / 11卷
关键词：
Angiotensin-converting enzyme inhibitor; Angiotensin receptor blocker; Angiotensin receptor neprilysin inhibitor; Heart failure; Sacubitril/valsartan;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：113 / 127
页数：14
相关论文
共 50 条
  • [31] Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure: An observational study of treatment rates and clinical outcome
    Gotsman, Israel
    Rubonivich, Shani
    Azaz-Livshits, Tanya
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2008, 10 (03): : 214 - 218
  • [32] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease
    Berger, Alan K.
    Duval, Sue
    Manske, Connie
    Vazquez, Gabriela
    Barber, Cheryl
    Miller, Leslie
    Luepker, Russell V.
    AMERICAN HEART JOURNAL, 2007, 153 (06) : 1064 - 1073
  • [33] Use or nonuse of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in patients hospitalized for acute heart failure
    Yoshikawa, Y.
    Tamaki, Y.
    Yaku, H.
    Yamamoto, E.
    Ozasa, N.
    Inuzuka, Y.
    Morimoto, T.
    Inoko, M.
    Nakagawa, Y.
    Kato, T.
    Kimura, T.
    EUROPEAN HEART JOURNAL, 2017, 38 : 909 - 909
  • [34] Time to switch angiotensin-converting enzyme inhibitors/angiotensin receptor blockers to sacubitril/valsartan in patients with cancer therapy-related cardiac dysfunction
    Xi, Qianlan
    Chen, Zijun
    Li, Tingming
    Wang, Liya
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2022, 50 (01)
  • [35] The Use of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Is Associated with the Recovered Ejection Fraction in Patients with Dilated Cardiomyopathy
    Enzan, Nobuyuki
    Matsushima, Shouji
    Ide, Tomomi
    Kaku, Hidetaka
    Tohyama, Takeshi
    Funakoshi, Kouta
    Higo, Taiki
    Tsutsui, Hiroyuki
    INTERNATIONAL HEART JOURNAL, 2021, 62 (04) : 801 - 810
  • [36] COMPARATIVE EFFECTIVENESS OF SACUBITRIL-VALSARTAN VERSUS ANGIOTENSIN CONVERTING ENZYME INHIBITORS / ANGIOTENSIN RECEPTOR BLOCKERS THERAPY ON RENAL OUTCOMES IN SYSTOLIC HEART FAILURE PATIENTS
    Deng, Y.
    Tan, N. Y.
    Yao, X.
    Sangaralingham, L.
    Shah, N. D.
    Rule, A. D.
    Burnett, J. C.
    Dunlay, S. M.
    Sangaralingham, S. J.
    VALUE IN HEALTH, 2020, 23 : S92 - S92
  • [37] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in atherosclerosis
    Lonn E.
    Current Atherosclerosis Reports, 2002, 4 (5) : 363 - 372
  • [38] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in heart failure patients with mid-range and preserved ejection fraction and clinical outcomes: from the KCHF Registry
    Yoshikawa, Y.
    Tamaki, Y.
    Yaku, H.
    Yamamoto, E.
    Ozasa, N.
    Inuzuka, Y.
    Morimoto, T.
    Kato, T.
    Kimura, T.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 328 - 328
  • [39] Angiotensin-converting enzyme inhibitors and β-blockers in African American heart failure patients
    McCullough, PA
    Philbin, EF
    Spertus, JA
    Sandberg, KR
    Kaatz, S
    AMERICAN HEART JOURNAL, 2002, 144 (05) : 920 - 921
  • [40] Cost of Heart Failure in Patients Receiving β-Blockers and Angiotensin-Converting Enzyme Inhibitors
    William S. Weintraub
    Hugh Kawabata
    Michele Tran
    Gilbert J. L’italien
    Roland S. Chen
    Clinical Drug Investigation, 2004, 24 : 255 - 264
12345